Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors
Otello Stampacchia steps down, Vikas Goyal to leave Morphic Board at the end of current term
April 28, 2021 16:01 ET | Source: Morphic Therapeutic Morphic Therapeutic Waltham, Massachusetts, UNITED STATES
WALTHAM, Mass., April 28, 2021 (GLOBE NEWSWIRE) Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing oral integrin therapies, today announced the appointment of Susannah Gray to its Board of Directors. Ms. Gray is an accomplished leader in healthcare finance and serves as a director on the boards of multiple healthcare companies. Ms. Gray was most recently the executive vice president of finance and strategy at Royalty Pharma.
Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.